Drug Trial Radar · NCT07105215
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Last checked: Nov 19, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
312
Planned (sponsor's estimate)
Start
Aug 11, 2025
Primary completion
Dec 31, 2027
Study completion May 31, 2030
Sponsor
- Lead sponsor
- RemeGen Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to evaluate the safety and tolerability of RC278; determine the maximum tolerated dose (MTD) and/or maximum administered dose (MAD) of RC278; and determine the recommended phase 2 dose (RP2D), and assess the efficacy of RC278 at the RP2D dose;
Conditions
- Solid Tumors
Interventions
RC278Drug
Intravenous (IV) administration of RC278 Q3W. Patients will continue treatment until unacceptable toxicities, disease progression, or any criterion for withdrawl from the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose-Limiting Toxicity (DLT)Time frame: 24 months
- Incidence and severity of adverse events/serious adverse events (graded according to NCI CTCAE v5.0)Time frame: 24 months
- Determine RP2D of RC278Time frame: 24 months
- MTD and/or MADTime frame: 24 months
- Investigator assessed ORR according to RECIST v1.1 criteriaTime frame: 24 months
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Sun Yat-sen University Cancer Center
Guangzhou, China · Recruiting
The First Affiliated Hospital, Zhejiang University School Of Medicine
Hangzhou, China · Recruiting
Cancer Hospital of Shandong First Medical University
Jinan, China · Recruiting
Jinan Central Hospital
Jinan, China · Recruiting
Shanxi Cancer Hospital
Taiyuan, China · Recruiting
Henan Cancer Hospital
Zhengzhou, China · Recruiting
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Fujian Medical University Union Hospital
Fuzhou, Fujian, China · Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China · Recruiting
The Second Affiliated Hospital of Guilin Medical University
Guilin, Guangxi, China · Recruiting
Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute
Nanning, Guangxi, China · Recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Recruiting
Anyang Cancer Hospital
Luoyan, Henan, China · Recruiting
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang, Henan, China · Recruiting
Nanyang Second General Hospital
Nanyang, Henan, China · Recruiting
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Wuhan, Hu'Nan, China · Recruiting
Hubei Cancer Hospital
Wuhan, Hubei, China · Recruiting
Tongji Hospital, Tongji Medical College of HUST, China
Wuhan, Hubei, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Jiangsu Province Hospital
Nanjing, Jiangsu, China · Recruiting
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China · Recruiting
Xuzhou Central Hospital
Xuzhou, Jiangsu, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China · Recruiting
The first Hospital of China Medical University
Shenyang, Liaoning, China · Recruiting
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China · Recruiting
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
Yunnan Tumor Hospital
Kunming, Yunnan, China · Recruiting
Sir Run Run Shaw Hospital, affiliated with Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.